Skip to content
Latest News
IP Group’s Shares Rise As Portfolio Company Plans IPO and Signs MoU With Oracle

Shares of IP Group (LON: IPO) are climbing after its portfolio company Oxford Nanopore Technologies has confirmed its intention to proceed with an initial public offering (IPO) as well as the signing of an MoU and i

Sam Boughedda
Superdry Shares Surged 14.9% on Upbeat Full-Year and Interim Trading Results

Shares of Superdry PLC (LON: SDRY) surged 14.9% as investors reacted to the positive trading results achieved over the 18 weeks to August 28, while its full-year results for the 2021 financial year showed significant improvements compared to fiscal 2

Simon Mugo
ValiRx (VAL) Shares Gain On New Evaluation Agreement

Shares of life science company ValiRx (LON: VAL) are gaining on Thursday after it announced an evaluation agreement with a London university to investigate a novel technology designed to treat breast cancer.

Sam Boughedda
The Nasdaq Composite Is on Track to End 6-Day Downtrend

The Nasdaq Composite opened today’s session trading below the 20-day exponential moving average (EMA) but had clawed back its losses by the time of writing and was back above this crucial indicator. The index has been on a six-day losing streak, a

Simon Mugo
GreenSky (GSKY) Stock Soared 53% on Goldman Sachs $2.2Bn Takeover Deal

Shares of GreenSky LLC (NASDAQ: GSKY) soared 53% after news emerged that Goldman Sachs has agreed to buy the speciality lender for a whopping $2.2 billion to expand its presence in the main street lending marketplace. The lofty valuation was respo

Simon Mugo
Eqtec Shares Remain Stuck Despite a New Strategy To Acquire Waste-to-Energy Projects

Since mid-July, shares of EQTEC PLC (LON: EQT) have been stuck trading sideways despite announcing its second acquisition of a waste-to-energy gasification plant in Croatia. The company acquired its first Croatian plant in early August to produce

Simon Mugo
Power Metal (POW) Shares Rallied 16.9% After Acquiring Uranium Properties

Shares of Power Metal Resources PLC (LON: POW) rallied 16.9% after announcing the acquisition of four new uranium exploration properties in Canada’s Saskatchewan province. The mining and exploration company own 100% of the new uranium properties s

Simon Mugo
Evgo Stock Price Edges Higher Premarket After Citigroup Started Covering the Stock

Shares of Evgo Inc (NASDAQ: EVGO) edged slightly higher during premarket trading after Citigroup initiated coverage of the stock and set a price target of $10. The investment bank maintained a neutral rating on the electric vehicle charging and so

Simon Mugo
LM Funding America (LMFA) Stock Gains As It Expands Into Crypto Mining

Shares of LM Funding America (NASDAQ: LMFA) are gaining premarket on the news it is expanding and diversifying its business operations by launching a cryptocurrency mining business.

Sam Boughedda
Indaptus Therapeutics (INDP) Stock Rallies After Receiving Notice Of Allowance For Patent

Shares of Indaptus Therapeutics (Nasdaq: INDP) are rallying premarket after news that the United States Patent and Trademark Office has issued a notice of allowance for claims related to the company’s platform techn

Sam Boughedda
Kodal Minerals Shares Surged 10.9% As Investors Await the Bouguoni Mining License

Shares of Kodal Minerals PLC (LON: KOD) surged 10.9% higher as investors await the issuance of the Bouguoni mining license that will unlock the premier lithium resource. Investors have been extremely patient with the company given the multi-year l

Simon Mugo
Nuwellis (NUWE) Stock Slides On News Of Public Offering

Medical device firm Nuwellis Inc's (NASDAQ: NUWE) share price is on the slide premarket after announcing an underwritten public offering. While the amount of share being

Sam Boughedda
Character Group Shares Plunge As Full Year Expectations Impacted By Supply Chain Issues

Toys, games and giftware firm Character Group (LON: CCT) shares have plunged on Wednesday after the company said supply chain and other issues have impacted its full-year outcome. The company said that the easing of Covid-19 restrictions has posit

Sam Boughedda
Sabien Technology (SNT) Shares Surge On Agreement With COF of South Korea

On Wednesday, Sabien Technology Group (LON: SNT) announced an agreement with City Oil Field Incorporated of South Korea (COF), sending its share price surging higher.  Th

Sam Boughedda
InfraStrata (INFA) Shares Spike On MoU With Navantia and Windar Renovables

InfraStrata (LON: INFA) shares are rising on Wednesday after announcing that it has signed a Memorandum of Understanding (MoU) with Navantia and Windar Renovables. The Mo

Sam Boughedda
MGC Pharmaceuticals (MXC) Shares Rise Following ArtemiC Update

Shares of European-based bio-pharma company MGC Pharmaceuticals (LON: MXC) are climbing on Wednesday after it provided an update in its proprietary nutraceutical food supplement, ArtemiC.

Sam Boughedda
Gulf Resources (GURE) Stock Rallies On Q3 and Full Year Guidance 

Shares of bromine, crude salt and specialty chemical products manufacturer Gulf Resources (Nasdaq: GURE) are rallying on Tuesday after providing income and revenue guidance for Q3 and the full year 2021. 

Sam Boughedda
Hurricane Energy (HUR) Shares Are Up 37.8% Over the Past Week on Bonds Buyback

Shares of Hurricane Energy PLC (LON: HUR) are up 37.8% over the past week after announcing that it had accepted to buy back bonds worth $77,984,000 out of the total outstanding bonds worth $230 million. The bonds repurchase transaction is set to b

Simon Mugo
Will the MiMedx Group (MDXG) Stock Price Keep Falling After Yesterday’s 59.6% Drop?

Shares of MiMedx Group Inc (NASDAQ: MDXG) were down a mere 2% during the premarket trading session as investors digested yesterday’s massive 59.6% drop occasioned by the release of its phase 2B clinical trial data. Now, you might be wondering why

Simon Mugo
aTyr Pharma (LIFE) Shares Are Up 34.1% Premarket Extending Yesterday’s Rally

Shares of aTyr Pharma Inc (NASDAQ: LIFE) were up 27.65% premarket building on yesterday’s impressive 66.97% rally after releasing positive phase 1b/2a clinical trial results for its ATYR1923 drug candidate. The successful clinical trial was conduc

Simon Mugo